Clinical Trial Update: The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 clinical trial evaluating SHR-7631 for injection in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SHR-7631 (SHR-7631)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED